valeant pharmaceuticals inte
Transactions by VALEANT PHARMACEUTICALS INTE (VRX) in the last 6 months
Pershing Square Capital Management, L.P. through its fund Pershing Square Holdings, Ltd. (ENXTAM:PSH) acquired 4.9% stake in Valeant Pharmaceuticals International, Inc. (TSX:VRX) for $3.3 billion on March 9, 2015. Pershing acquired 16.5 million shares of Valeant. Tim Burt of StockWell Communications acted as public relations advisor in the deal. Davies Ward Phillips & Vineberg LLP acted as the legal advisor to Pershing Square Holdings, Ltd.
Valeant Pharmaceuticals International, Inc (TSX: VRX) entered into a stalking horse asset purchase agreement to acquire Provenge product and certain other assets of Dendreon Corp (OTCPK:DNDN.Q) for approximately $300 million in cash on January 29, 2015. Valeant Pharmaceuticals will deposit 10% of consideration into escrow which would be released at closing. Under the terms of the agreement, Valeant Pharmaceuticals International, Inc will acquire the world-wide rights ...
Valeant Pharmaceuticals International, Inc. (TSX:VRX) announces a share repurchase program. Under the program, the company will repurchase up to $2,000 million worth of its common shares, senior notes and/or other debt or shares that may be issued prior to the completion of the program. The repurchases of common shares will be made at prevailing market prices of such shares on the NYSE or the TSX, as the case may be, at the time of the acquisition and will be made in ...
Valeant Pharmaceuticals International, Inc. (TSX:VRX) acquired Nicox Inc. from Nicox SA (ENXTPA:COX) for $20 million in cash on November 17, 2014. Valeant has acquired Nicox Inc. for $10 million in cash, plus further cash payments of up to $10 million based upon Valeant achieving certain sales targets with the transferred products. Valeant has acquired most of the Nicox commercial infrastructure in the US associated with diagnostics, while Nicox has retained a number ...
|Actavis plc||$289.81 USD||+0.07|
|Astellas Pharma Inc||¥1,875 JPY||+5.50|
|Bristol-Myers Squibb Co||$65.32 USD||+0.66|
|Mylan NV||$73.05 USD||-0.84|
|Sun Pharmaceutical Industries Ltd||958.45 INR||+10.70|
|View Industry Companies|